Open Science and the Role of Cardiology Journals in the COVID-19 Pandemic

Claudio Tinoco Mesquita

doi:10.36660/ijcs.20200191

Abstract

In July 2020, Brazil has the world’s second highest Covid-19 death toll. The COVID-19 pandemic is spreading fast in America. Since the first case of COVID-19 was confirmed, it took 114 days in Brazil (February 26-June 19) and 98 days in the USA (January 21-April 29) for the number of cases to reach more than 1,000,000. Parallel to the rapid growth of COVID-19 cases, there has been a progression in the number of scientific publications. Until June 2020, more than [...]

Highlights

Pós-Graduação em Ciências Cardiovasculares, Ebserh/HUAP, Universidade Federal Fluminense,[1] Niterói, RJ - Brazil Hospital Pró-Cardíaco,[2] Rio de janeiro, RJ – Brazil Editor-in-Chief International Journal of Cardiovascular Sciences, Sociedade Brasileira de Cardiologia,[3] Rio de Janeiro, RJ - Brazil “It is not the strongest of the species that survives, not the most intelligent that survives
Our aim is to discuss the importance of Open Science during the COVID-19 pandemic and the role of cardiology journals in this special moment
As a task force of the IJCS editors and reviewers, COVID-19 manuscripts are under fast track to reduce the time to response to the authors to 15 days and accelerate the time from submission to publication, and importantly, of reliable data

Summary

Introduction

Pós-Graduação em Ciências Cardiovasculares, Ebserh/HUAP, Universidade Federal Fluminense,[1] Niterói, RJ - Brazil Hospital Pró-Cardíaco,[2] Rio de janeiro, RJ – Brazil Editor-in-Chief International Journal of Cardiovascular Sciences, Sociedade Brasileira de Cardiologia,[3] Rio de Janeiro, RJ - Brazil “It is not the strongest of the species that survives, not the most intelligent that survives. Until June 2020, more than 25,800 papers about COVID-19 were published in PubMed (17,800 open access - 69%). The Journal of the American Medical Association (JAMA), for example, received more than 11,000 submissions from January 1 to June 1, 2020, compared with approximately 4,000 submissions during the same period in 2019.1 The International Journal of Cardiovascular Sciences is facing a similar situation with more than doubled manuscripts submitted.

Objectives

Results

Conclusion